EPO and Renal insufficiency: While recombinant human EPO increases platelet count in patients suffering from renal failure [81], in vitro studies have indicated the stimulatory effect of EPO on megakaryocytic proliferation, in combination with other megakaryocytic cytokines such as TPO [82].